Gabapentin for Parkinsonism:A Double-Blind Placebo-Controlled, Crossover Trial
Am J med 102:60-66, Olson,W.L.,et al, 1997
Nasal Benzodiazepines for Management of Acute Childhood Seizures
Lancet 349:222-223, Wallace,S.J., 1997
Carbamazepine and Fatal Eosinophilic Myocarditis
NEJM 336:878-879, Salzman,M.B.,et al, 1997
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997
Predictive Power of Duplex Ultrasonography in Asymptomatic Carotid Disease
Ann Int Med 127:13-20, Lewis,R.F.,et al, 1997
Ischemic Stroke After Acute Myocardial Infarction
Stroke 28:762-767, Mooe,T.,et al, 1997
Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997
Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997
Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997
Intracerebral Hemorrhage in Blacks, Risk Factors, Subtypes, and Outcome
Stroke 28:961-964, Qureshi,A.I.,et al, 1997
Primary Care Physician-Reported Secondary and Tertiary Stroke Prevention Practices
Stroke 28:746-751, Goldstein,L.B.,et al, 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Stroke Recurrence:Predictors, Severity, and Prognosis, The Copenhagen Stroke Study
Neurol 48:891-895, Jorgensen,H.S.,et al, 1997
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997
Knowledge of Risk Among Patients at Increased Risk for Stroke
Stroke 28:916-921, Samsa,G.P.,et al, 1997
Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Butorphanol (Stadol) :A Study in Problems of Current Drug Information and Control
Neurol 48:1156-1160, Fisher,M.A.&Glass,S., 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Tiagabine Therapy for Complex Partial Seizures
Arch Neurol 54:959-601, Sachdeo,R.C.,et al, 1997
Brachial Neuritis Following Routine Childhood Immunizatioon for DTP:Two Cases & Review of Literature
Pediatrics 99:602-603, Hamati-Haddad,A.&Fenichel,G., 1997
Familial Intracranial Aneurysms
Lancet 349:380-384, Ronkainen,A.,et al, 1997
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997
Case-Control Study of Stroke and the Quality of Hypertension Control in North West England
BMJ 314:272-276, Du,X.,et al, 1997
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997
Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997
Echocardiographic Identif of Cardiovascular Sources of Emboli to Guide Clin Manag of Stroke:Cost-Effec Analysis
Ann Int Med 127:775-787, McNamara,R.L.,et al, 1997
Lumbar Puncture Needn't Be a Headache, Use Blunt Needles and No Bed Rest
BMJ 315:1324-1325, Broadley,S.A.&Fuller,G.N., 1997
Improving Interobserver Variation in Reporting Gadolinium-Enhancing MRI Lesions in Multiple Sclerosis
Neurol 49:1682-1688, Barkhof,F.,et al, 1997
A Controlled Trial of an Educational Program to Prevent Low Back Injuries
NEJM 337:322-328, Daltrov,L.H.,et al, 1997
Epilepsy in Childhood
BMJ 315:924-930, Neville,B.G.R., 1997
Electroconvulsive Therapy for Treatment of Intractable Seizures, Initial Findings in Two Children
Neurol 49:1389-1392, Greisemer,D.A.,et al, 1997
An Infant with Encephalitis
Lancet 350:1594, Yeung,W.L.,et al, 1997
Melatonin"A Clinical Perspective
Ann Neurol 42:545-553, Penev,P.D.,et al, 1997
Unilateral Hypnic Headache:A Case Study
Neurol 49:1749-1751, Gould,J.D.&Silberstein,S.D., 1997
Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997
Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997